Indian pharma market grew 10.2% yoy in January 2026
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
HCG clinicians contributing to one of the largest bodies of oncology research from India
Leading the showcase is FCT iStream, Fujifilm’s latest CT scanner built on a “Less is More” design philosophy
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
Subscribe To Our Newsletter & Stay Updated